Rigel Pharma (RIGL) Tops Q3 EPS by 146c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $47.22 -0.32%
EPS Growth %: -34.9%
Financial Fact:
Interest income: 110K
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -34.9%
Financial Fact:
Interest income: 110K
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of $1.46. Revenue for the quarter came in at $69.46 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- Goldman Sachs Starts Manipal Health Enterprises (MANIPALH:IN) at Buy
- Jefferies Reiterates Buy Rating on UroGen Pharma (URGN)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
